and the mixture was warmed up to rt. After stirring for 3–4 h,
the reaction mixture was washed with aqueous KHSO4 (5%).
CH2Cl2 was used to extract the aqueous layer (¥ 2). The combined
organic layers were washed with water and brine, and dried over
Na2SO4. Filtration and removal of solvent under vacuum gave a
colorless oil, which solidified upon cooling in a refrigerator. Silica
gel column chromatography (hexane:EtOAc = 1:1 to 1:3) gave 2
(550 mg, 2.49 mmol, 70%) as a white solid. Compounds 1, 3, and
5 were prepared in a similar manner.
evaporated under vacuum to leave an oily residue. The product
was purified by column chromatography on silica using a gradient
eluent of EtOAc/hexane starting with a 1:9 and reaching a 1:1
1
ratio to give 12 (1.5 g, 3.2 mmol, 46%). H NMR (400 MHz,
CDCl3) d (ppm): 7.35 (m, 5H), 5.23 (d, 1 H), 5.13 (s, 2H), 4.52 (m,
1H), 3.60 (dd, 2H), 2.49 (m, 2H), 2.24 (m, 1H), 2.01 (m, 1H), 1.45
(s, 9H), 1.43 (s, 9H). SSI-LCMS: (m/z) 489.7 [M + Na]+; 506.5
[M + K]+ (MWcalcd = 490.2 [M + Na]+; 506.2 [M + K]+).
Preparation of monomer 4. (Scheme S1†). Triethylsilane
(1.2 mL, 7.5 mmol) was added to a solution of 12 (1.4 g, 3 mmol)
in CH2Cl2 (6.2 mL) under argon. TFA (2.89 mL, 39 mmol) was
then added. The reaction was monitored by HPLC and LCMS
and required 24 hrs to reach 95% completion. The solvent was
removed under vacuum and the residue was dissolved in water
and lyophilized to give a solid (1.2 g, 2.6 mmol, 87%). Without
any further purification, a solution of the deprotected product
(1.0 g, 2.2 mmol) and (iPr)2NEt (0.8 mL, 4.7 mmol) in CH2Cl2
(120 mL) was added dropwise to a CH2Cl2 (130 mL) solution
of PyBop (1.5 g, 2.8 mmol) over a period of 2 h. The reaction
was then followed by LCMS and TLC (silica, EtOAc/hexane 1:1)
and was complete after 1 additional hr. The organic solution was
washed with water (2 ¥ 50 mL) and brine (1 ¥ 50 mL), dried
(Na2SO4), and evaporated under vacuum to leave an oily residue.
The product was purified by column chromatography on silica
using EtOAc/pentane (1:1) to afford an oily residue that solidified
upon sitting (400 mg, 1.4 mmol, 64%). 1H NMR (400 MHz,
CDCl3) d (ppm): 7.36 (m, 5H), 7.17 (bs, 1H), 5.14 (s, 2H), 4.10
(m, 1H), 3.84 (d, J = 15.2 Hz, 1H), 3.53 (dd, J = 1.6, 15.2 Hz
1H), 2.61 (t, J = 6.8 Hz, 2H), 2.35 (m 1H), 2.10 (m, 1H). ESI-MS
(m/z) 294.0796 [M + H]+ (MWcalcd = 294.0795).
Preparation of 13. (Scheme S1†). HF (10 mL) was introduced
to a mixture of monomer 4 (118 mg, 0.4 mmol) and anisole (88 mL,
0.8 mmol) at -78 ◦C. The solution was then warmed to 0 ◦C and the
reaction stirred for 1 h. The excess HF was removed by flowing N2.
The solid was dissolved in Et2O (5 mL) and extracted with water
(5 ¥ 10 mL). The combined aqueous extracts were concentrated
under reduced pressure and lyophilized to yield a white solid
identified as compound 13 (70 mg, 0.34 mmol, 90%). The solid
was purified by preparative HPLC. In column chromatography
(SiO2, CH2Cl2:MeOH 95/5) the material decomposed. 1H NMR
(CD3OD): d 1.94 (td, 1H, J = 7.3, 14.7 Hz,), 2.20 (dtd, 1H, J = 7.3,
13.4, 14.7 Hz,), 2.48 (t, 2H, J = 7.3 Hz), 3.56 (d, 1H, J = 15.0 Hz),
4.05 (d, 1H, J = 15.0 Hz), 4.23 (dd, 1H, J = 5.45, 7.87 Hz). ESI-MS
(m/z) 204.0323 [M + H]+ (MWcalcd = 204.0330).
Compound 1. 1H NMR (400 MHz, CDCl3): d 7.39–7.30 (m,
5H), 6.22 (br s, 1H), 4.58 (d, J = 11.7 Hz, 1H), 4.54 (d, J =
11.7 Hz, 1H), 4.25 (ddd, J = 2.6, 4.1, 6.7 Hz, 1H), 3.87 (dd, J =
4.1, 10.1 Hz, 1H), 3.81 (dd, J = 6.8, 10.2 Hz, 1H), 3.81 (d, J =
15.1 Hz, 1H), 3.64 (dd, J = 1.6, 15.1 Hz, 1H). ESI-MS (m/z)
252.0682 [M + H]+ (MWcalcd = 252.0689).
Compound 2. 1H NMR (500 MHz, CDCl3): d 7.36–7.20 (m,
5H), 6.20 (brs, 1H), 4.27 (ddd, J = 3.0, 4.5, 9.0 Hz, 1H), 3.75
(d, J = 15.2 Hz, 1H), 3.38 (dd, J = 4.6, 14.4 Hz, 1H), 3.35 (dd,
J = 1.0, 15.6 Hz, 1H), 2.90 (dd, J = 9.1, 14.6 Hz, 1H). 13C NMR
(125 MHz, CDCl3): d 198.60, 167.42, 134.90, 129.21 (2C), 129.19
(2C), 127.73, 63.62, 36.05, 31.44. ESI-MS (m/z) 222.0584 [M + H]+
(MWcalcd = 222.0583).
Compound 3. 1H NMR (400 MHz, CDCl3): d 6.32 (br s, 1H),
4.03 (ddd, J = 3.7, 4.7, 9.3 Hz, 1H), 3.84 (d, J = 15.1 Hz, 1H),
3.60 (dd, J = 1.5, 15.1 Hz, 1H), 1.89 (ddd, J = 4.8, 9.1, 14.0 Hz,
1H), 1.82–1.72 (m, 1H), 1.55 (ddd, J = 5.1, 9.2, 14.2 Hz, 1H),
1.00 (d, J = 6.5 Hz, 3H), 0.96 (d, J = 6.5 Hz, 3H). ESI-MS (m/z)
188.0739 [M + H]+ (MWcalcd = 188.0740).
Compound 5. 1H NMR (500 MHz, DMSO-d6): d 9.15 (br s,
2H), 8.29 (s, 1H), 7.44–7.30 (m, 10H), 5.25 (s, 2H), 5.05 (s, 2H),
4.22 (ddd, J = 3.2, 4.8, 7.8 Hz, 1H), 4.01 (d, J = 14.7 Hz, 1H),
3.95–3.83 (m, 2H), 3.48 (dd, J = 1.5, 14.7 Hz, 1H), 1.77–1.51 (m,
4H). ESI-MS (m/z) 499.1656 [M + H]+ (MWcalcd = 499.1646).
Preparation of 11. (Scheme S1†). Isobutyl chloroformate
(1.35 mL, 10.4 mmol) was added to a solution of Boc-Glu(OBz)-
OH (3.37 g, 10 mmol) and (iPr)2NEt (1.65 mL, 10 mmol) in
anhydrous THF (30 mL) cooled at -20 ◦C under argon. The
mixture was allowed to stir for 20 min at -20 ◦C, after which
time a white suspension was formed. A solution of NaSH (0.67 g,
12 mmol) in DMF (5 mL) was then added and the yellow
solution was stirred at 0 ◦C for 4 h, after which time the TLC
(silica, EtOAc/hexane/HOAc 3:7:0.5) showed completion of the
reaction. The solution was then acidified to pH = 3 with 1 N HCl
and the aqueous layer was extracted with EtOAc (3 ¥ 20 mL).
The combined organic layers were washed with water (1 ¥ 20 mL),
dried (Na2SO4), and evaporated under vacuum to afford the oily
product 11. The product was used without further purification.
Preparation of 14. (Scheme S3†). HF (10 mL) was introduced
to a mixture of monomer 5 (200 mg, 0.4 mmol) and anisole (88 mL,
0.8 mmol) at -78 ◦C. The solution was then warmed to 0 ◦C and
the reaction stirred for 1 h. The excess HF was removed by flowing
N2. The solid was dissolved in Et2O (10 mL) and extracted with
0.1 M HCl (3 ¥ 10 mL). The aqueous phase was washed with Et2O
(2 ¥ 15 mL), concentrated under vacuum, and lyophilized to afford
a white solid identified as 14 (91 mg, 0.39 mmol, 98%). 1H NMR
(CD3OD) d 1.68–2.14 (m, 6H), 3.67 (d, 1H, J = 15.0 Hz,), 4.19
(d, 1H, J = 15.0 Hz), 4.3–4.38 (m, 1H). ESI-MS (m/z) 231.0909
[M + H]+ (MWcalcd = 231.0910).
Preparation of 12. (Scheme S1†). t-Butyl bromoacetate (2.0 g,
10 mmol) was added to a stirred solution of crude 11 (2.5 g,
7.0 mmol) in MTBE (50 mL) at 0 ◦C followed by the addition
of Cs2CO3 (2.0 g). The cooling bath was then removed and the
mixture was stirred at rt. The reaction was followed by TLC
(silica, EtOAc/hexane/HOAc 1:1:0.1) and was complete within
2 h. EtOAc (30 mL) and water (30 mL) were added to the reaction
mixture and then the organic layer was separated, washed with
water (2 ¥ 15 mL) and brine (1 ¥ 15 mL), dried (Na2SO4), and
Preparation of 17. (Scheme S1†). Compounds 1519 and 1620
were prepared as reported previously. To a MTBE solution (5 mL)
2882 | Org. Biomol. Chem., 2009, 7, 2878–2884
This journal is
The Royal Society of Chemistry 2009
©